Suvretta Capital Management, LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.91 Billion
- Q2 2025
A detailed history of Suvretta Capital Management, LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 4,955,000 shares of KALV stock, worth $60.7 Million. This represents 1.93% of its overall portfolio holdings.
Number of Shares
4,955,000
Previous 4,913,012
0.85%
Holding current value
$60.7 Million
Previous $56.7 Million
1.16%
% of portfolio
1.93%
Previous 2.48%
Shares
18 transactions
Others Institutions Holding KALV
# of Institutions
149Shares Held
54.3MCall Options Held
1.07MPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$82.4 Million15.07% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$60.5 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.9 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$57.3 Million2.78% of portfolio
-
Capital World Investors Los Angeles, CA3.18MShares$38.9 Million0.01% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $301M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...